T′Amoxifen Citrate 54965-24-1 N`Olvadex Powder For Anti Estrogen

Product Details:
Place of Origin: China
Brand Name: Filter
Certification: GMP
Model Number: 54965-24-1
Payment & Shipping Terms:
Minimum Order Quantity: Negotiable
Price: Negotiable
Packaging Details: Foil Bag
Delivery Time: within 5hours
Payment Terms: T/T, Western Union, MoneyGram, Bitcoin
Supply Ability: 100kg/Month

Detail Information

Name: Tamoxifen Foam: White Powder
Packing: Foil Bag Min Order Quantity: 50g
Usage: Injectable Function: Treat Certain Types Of Cancer
CAS: 54965-24-1 Purity: 98%min
Grade: UPS
High Light:

anabolic steroid hormones


testosterone propionate powder

Product Description

T′amoxifen Citrate 54965-24-1 N`Olvadex Powder for Anti-Estrogen




Product name Tamoxi Citrate Nolvad
Test Analysis Standard Results
Characteristics White crystalline powder conforms
Assay 99 ~ 101.0% 99.51%
Loss on drying ≤0.5% 0.24%
Identification IR,UV conform conforms
Residue on ignition ≤0.2% 0.06%
Iron ≤0.005% 0.0016%
Heavy metals ≤0.001% 0.0006%
Related substances Total:≤1.0% 0.37%
Individual:≤0.5% 0.17%
E-isomer ≤0.3% 0.20%
Organic volatile impurities conform conform
Conclusion This batch is complies with USP 30.



tamoxifeni citras, Zitazonium

Foreign brand name:

Apo-Tamox, Clonoxifen, Dignotamoxi, Ebefen, Emblon, Estroxyn, Fentamox, Genox, Gen-Tamoxifen, Jenoxifen, Kessar, Ledertam, Lesporene, Nolgen, Noltam, Nolvadex-D, Nourytam, Novofen, Novo-Tamoxifen, Oestrifen, Oncotam, PMS-Tamoxifen, Soltamox, Tamax, Tamaxin, Tamifen, Tamizam, Tamofen, Tamoxasta, Zemide

Chemical structure:

1.(Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-hydroxy-1,2,3-propanetricarboxylate

2.(Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate




Treatment of female surname with recurrent metastatic adenocarcinoma.

Used as an adjuvant treatment for breast cancer metastasis after surgery to prevent recurrence.



The citrate salt of an antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. Tamoxifen also down-regulates protein kinase C (PKC) expression in a dose-dependant manner, inhibiting signal transduction and producing an antiproliferative effect in tumors such as malignant glioma and other cancers that overexpress PKC. Check for active clinical trials using this agent.



For the treatment of advanced, recurrent breast and ovarian cancer

A drug used to treat certain types of breast cancer in women and men. It is also used to prevent breast cancer in women who have had ductal carcinoma in situ (abnormal cells in the ducts of the breast) and in women who are at a high risk of developing breast cancer. It is also being studied in the treatment of other types of cancer. Tamoxifen citrate blocks the effects of the hormone estrogen in breast tissue, which may help keep breast cancer cells from growing. It is a type of selective estrogen receptor modulator (SERM). Tamoxifen is the active ingredient of tamoxifen citrate.



Peptide List:

T′Amoxifen Citrate 54965-24-1 N`Olvadex Powder For Anti Estrogen 0

T′Amoxifen Citrate 54965-24-1 N`Olvadex Powder For Anti Estrogen 1

T′Amoxifen Citrate 54965-24-1 N`Olvadex Powder For Anti Estrogen 2





Get in touch with us

Enter Your Message

You Might Be Into These